SCHEMBL25503201

SCHEMBL25503201

Cc1cnc(Br)c(Cl)n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16283591 0.81
SCHEMBL27823310 0.77
SCHEMBL1560977 0.77
SCHEMBL273776 0.75
SCHEMBL599850 0.75
SCHEMBL29408229 0.75
SCHEMBL10925625 0.75
SCHEMBL30683717 0.75
SCHEMBL23266021 0.71
SCHEMBL669218 0.71

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240207300-A1 COMBINATION THERAPIES INCLUDING MYT1 INHIBITORS SINAI HEALTH SYSTEM (CA) 2024-06-27 US disclosed
US-20230158022-A1 METHODS OF USING MYT1 INHIBITORS REPARE THERAPEUTICS INC. (CA) 2023-05-25 US disclosed
US-20230151014-A1 COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF PREPARING COMPOUNDS AND OF THEIR USE REPARE THERAPEUTICS INC. (CA) 2023-05-18 US disclosed